MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization

Joost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al. · 2009

Read MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization by Joost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007790.txt.

Description

Joost Kreijtz and co-authors published a study in PLOS ONE in 2009. It tests a vaccine against H5N1 bird flu in mice. Human infections with H5N1, reported often since 2003, are frequently deadly. A pandemic strain could emerge from these viruses, so vaccines are wanted.

The vaccine uses a harmless carrier virus, MVA, fitted with H5N1 parts. A single immunization at low dose protected mice. Protection crossed clades, meaning it covered differing virus branches. Cross-clade cover at low dose is exactly what pandemic stockpiles need. The study supports MVA as a platform for bird flu vaccines.

Catalog record

CREATORJoost H. C. M. Kreijtz, Yasemin Suezer, Gerrie de Mutsert et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007790

Browse the full library · About the Tower of Babel